KPV
Batch #010013 · Research use only.
KPV (Lys-Pro-Val) is a naturally derived tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH) and is widely studied for its potent anti-inflammatory and immunomodulatory properties. In research settings, KPV has gained attention for its targeted ability to influence inflammatory signaling without broader systemic effects seen in larger peptide structures.
Product overview
KPV is a research-grade peptide composed of the amino acid sequence Lys-Pro-Val, engineered for stability and biological activity. Preclinical research associates KPV with modulation of pro-inflammatory cytokines, regulation of immune responses, and protective effects in models of gastrointestinal and epithelial inflammation. Its small size and targeted action make it a valuable tool in focused inflammation research.
Key research features
Anti-inflammatory pathway research:
KPV is widely investigated for its ability to downregulate pro-inflammatory cytokines and signaling pathways, including those associated with NF-κB activity, making it relevant in experimental models of inflammation.
Gastrointestinal and epithelial studies:
Studies suggest KPV may support intestinal barrier integrity and reduce inflammation in gut-related research models, positioning it as a key peptide in gastrointestinal and epithelial health research.
Immune modulation:
Research indicates KPV may influence immune response without broad systemic activation, supporting its use in studies examining localized inflammation and immune balance.
KPV Suggested Use:
Typical Dose: 250–500 mcg per dose
Route: Subcutaneous injection or oral (depending on format)
Frequency: 1–2 times daily
Duration: 2–4 weeks, or as recommended by a healthcare professional